RxDoctor Payments Data

Katherine Napier, APRN

Family · Bowling Green, KYNPI 1316201379

Payments from drug & device makers

$1,039in general payments, 2019–2025

Across 57 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$435
  • Amgen$97
  • Pfizer$78
  • Vital Connect, Inc$76
  • Medtronic$72
  • Abiomed$54
  • plus $228 from 11 others

What the payments were for

  • Food & beverage$1,039100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,039 in reported general payments places this provider in the 65th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$115,621
Medicare patients
601
Services billed
2,929

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban507$454,795
EntrestoSacubitril/Valsartan205$167,085
Praluent PenAlirocumab48$32,081
FarxigaDapagliflozin Propanediol37$31,363
Repatha SureclickEvolocumab39$29,561
XareltoRivaroxaban34$26,016
Ranolazine ErRanolazine280$19,857
BrilintaTicagrelor21$18,717
JardianceEmpagliflozin15$15,358
QuliptaAtogepant12$15,261
Dofetilide113$14,029
Metoprolol Succinate593$7,168
CorlanorIvabradine Hcl11$6,306
Dabigatran EtexilateDabigatran Etexilate Mesylate21$3,926
Prasugrel Hcl19$3,399

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$78$454,795507 claims
NovartisEntresto$435$167,085205 claims
Johnson & JohnsonXarelto$27$26,01634 claims
AbbVieQulipta$19$15,26112 claims
AmgenCorlanor$97$6,30611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,374 family providers in Kentucky.

Other family in Bowling Green

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →